Intuitive Surgical, Inc. $ISRG Stock Holdings Lifted by Sax Wealth Advisors LLC

Key Points

• Sax Wealth Advisors LLC significantly increased its holdings in Intuitive Surgical by 218.1% during the second quarter, now owning 2,456 shares valued at approximately $1.33 million.
• An array of institutional investors have recently boosted their stakes in Intuitive Surgical, with hedge funds collectively owning 83.64% of the company's stock.
• Analysts have varying perspectives on the stock, with targets ranging from $450.00 to $595.00, and a consensus average target price of $589.43 indicating a "Moderate Buy" rating.

Sax Wealth Advisors LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 218.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,456 shares of the medical equipment provider's stock after purchasing an additional 1,684 shares during the quarter. Sax Wealth Advisors LLC's holdings in Intuitive Surgical were worth $1,334,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chilton Capital Management LLC lifted its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. TD Capital Management LLC lifted its position in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Evercore ISI cut their price objective on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating for the company in a research report on Tuesday. BTIG Research reissued a "buy" rating and set a $571.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $589.43.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company's stock, valued at $504,898.14. This represents a 23.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $448.09 on Thursday. The firm has a market cap of $160.63 billion, a PE ratio of 62.50, a price-to-earnings-growth ratio of 4.64 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock's 50 day simple moving average is $460.50 and its 200 day simple moving average is $499.05.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.78 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.